Date	Chamber	Action
6/9/2023	Senate	Public Act . . . . . . . . . 103-0065

Statutes Amended In Order of Appearance

225 ILCS 95/4

from Ch. 111, par. 4604

225 ILCS 95/5.5

225 ILCS 95/6

from Ch. 111, par. 4606

225 ILCS 95/7

from Ch. 111, par. 4607

225 ILCS 95/7.5

225 ILCS 95/7.7

225 ILCS 95/7.8 new

225 ILCS 95/7.9 new

225 ILCS 95/17

from Ch. 111, par. 4617

225 ILCS 95/21

from Ch. 111, par. 4621

720 ILCS 570/102

from Ch. 56 1/2, par. 1102

720 ILCS 570/303.05

Synopsis As Introduced
Amends the Physician Assistant Practice Act of 1987. Changes the definition of "physician assistant", "physician assistant practice", "board", and "collaborating physician". Provides that a physician assistant shall be deemed by law to possess the ability to prescribe, dispense, order, administer, and procure drugs and medical devices without delegation of such authority by a physician. Provides that such ability shall include the prescribing of Schedule II, III, IV, and V controlled substances. Provides that to prescribe Schedule II, III, IV, or V controlled substances under the Act, a physician assistant shall obtain a mid-level practitioner controlled substances license. Provides that when a written collaboration agreement is required under the Act, delegation of prescriptive authority by a physician is not required. Provides that a physician assistant who files with the Department of Financial and Professional Regulation a notarized attestation of completion of at least 250 hours of continuing education or training and at least 2,000 hours of clinical experience after first attaining national certification shall not require a written collaborative agreement. Provides the specified scope of practice of a physician assistant with optimal practice authority. Provides that a physician assistant shall be able to hold more than one professional position. Makes changes in provisions concerning the physician assistant title, collaboration requirements, and the written collaborative agreement. Makes other changes and corresponding changes to the Act and to the Illinois Controlled Substances Act.

Senate Committee Amendment No. 2

	Deletes reference to:
	225 ILCS 95/7.8 new

225 ILCS 95/7.9 new

225 ILCS 95/17

225 ILCS 95/21

720 ILCS 570/102

720 ILCS 570/303.05

	Adds reference to:
	225 ILCS 95/7.6 new

Replaces everything after the enacting clause. Amends the Physician Assistant Practice Act of 1987. Provides that any physician assistant required to enter into a written collaborative agreement with a collaborating physician is authorized to continue to practice for up to 90 days after the termination of a written collaborative agreement, provided the physician assistant seeks any necessary collaboration at a local hospital and refers patients who require services beyond the training and experience of the physician assistant to a physician or other health care provider. Provides that physicians and physician assistants who work in a federally qualified health center are exempt from specified collaborative ratio restriction requirements. Adds physician assistants providing services in federally qualified health centers to provisions that authorize certain physician assistants to provide services without a written collaborative agreement and to prescribe certain controlled substances. Defines "federally qualified health center". Makes conforming and other changes.

Actions 

Date	Chamber	Action
1/31/2023	Senate	Filed with Secretary by Sen. Ann Gillespie
1/31/2023	Senate	First Reading
1/31/2023	Senate	Referred to Assignments
2/6/2023	Senate	Added as Chief Co-Sponsor Sen. Laura M. Murphy
2/7/2023	Senate	Assigned to Licensed Activities
2/22/2023	Senate	Added as Co-Sponsor Sen. Javier L. Cervantes
2/23/2023	Senate	Postponed - Licensed Activities
2/23/2023	Senate	Added as Co-Sponsor Sen. Terri Bryant
3/9/2023	Senate	Postponed - Licensed Activities
3/10/2023	Senate	Rule 2-10 Committee Deadline Established As March 24, 2023
3/23/2023	Senate	Postponed - Licensed Activities
3/23/2023	Senate	Rule 2-10 Committee Deadline Established As March 31, 2023
3/24/2023	Senate	Senate Committee Amendment No. 1 Filed with Secretary by Sen. Ann Gillespie
3/24/2023	Senate	Senate Committee Amendment No. 1 Referred to Assignments
3/28/2023	Senate	Senate Committee Amendment No. 1 Assignments Refers to Licensed Activities
3/28/2023	Senate	Senate Committee Amendment No. 2 Filed with Secretary by Sen. Ann Gillespie
3/28/2023	Senate	Senate Committee Amendment No. 2 Referred to Assignments
3/29/2023	Senate	Senate Committee Amendment No. 2 Assignments Refers to Licensed Activities
3/29/2023	Senate	Senate Committee Amendment No. 2 Adopted; Licensed Activities
3/29/2023	Senate	Senate Committee Amendment No. 1 Postponed - Licensed Activities
3/30/2023	Senate	Do Pass as Amended Licensed Activities; 009-000-000
3/30/2023	Senate	Placed on Calendar Order of 2nd Reading
3/30/2023	Senate	Second Reading
3/30/2023	Senate	Placed on Calendar Order of 3rd Reading March 31, 2023
3/31/2023	Senate	Third Reading - Passed; 052-000-000
3/31/2023	Senate	Senate Committee Amendment No. 1 Tabled Pursuant to Rule 5-4(a)
3/31/2023	Senate	Added as Co-Sponsor Sen. Mattie Hunter
3/31/2023	House	Arrived in House
3/31/2023	House	Chief House Sponsor Rep. Lakesia Collins
4/11/2023	House	First Reading
4/11/2023	House	Referred to Rules Committee
4/11/2023	House	Assigned to Health Care Licenses Committee
4/19/2023	House	Do Pass / Short Debate Health Care Licenses Committee; 012-000-000
4/19/2023	House	Placed on Calendar 2nd Reading - Short Debate
5/3/2023	House	Second Reading - Short Debate
5/3/2023	House	Placed on Calendar Order of 3rd Reading - Short Debate
5/8/2023	House	Third Reading - Short Debate - Passed 103-000-000
5/8/2023	House	Added Alternate Co-Sponsor Rep. Dave Severin
5/8/2023	House	Added Alternate Co-Sponsor Rep. Dagmara Avelar
5/8/2023	Senate	Passed Both Houses
6/6/2023	Senate	Sent to the Governor
6/9/2023	Senate	Governor Approved
6/9/2023	Senate	Effective Date January 1, 2024
6/9/2023	Senate	Public Act . . . . . . . . . 103-0065

Back To Top